Wikipedia -WSS

Wikipedia

author：knowledge 2025-10-02 22:56:42 - browse：14135

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： The Affordable Care Act has saved billions in health care costs

WSS

Why you shouldn’t ask, “What country has the best health care?”

Why Medicare shouldn’t cover every FDA

Wisconsin governor employs partial veto to fund schools for 4 centuries

Philips to halt sales of sleep apnea machines in U.S.

Eisai exec who led development of Alzheimer’s drug to retire

FTC sues over Novant Health acquisition of two N.C. hospitals

hotspot

Wikipedia

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Medicare proposal to cover medical devices draws a mixed reaction

Recent heat wave in the Mediterranean caused by climate change: Study

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Pancreatic cancer early detection could be helped by AI

Psychedelics group wrestles with new pharma identity

White House announces new plan to address the growing threat of xylazine in overdose crisis

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicare wants to send $9 billion to 340B hospitals

explore

Merck, Johnson & Johnson CEOs will testify on high drug prices

Zyn nicotine pouches become unlikely player in latest culture war

The Affordable Care Act has saved billions in health care costs

Philips to halt sales of sleep apnea machines in U.S.

Health Care Service Corp to buy Cigna Medicare Advantage plans

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

entertainment

focus

hotspot

leisure time